JOINN Laboratories (China) Co., Ltd. Class H (HK:6127) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
JOINN Laboratories (China) Co., Ltd. has released additional information regarding its ongoing connected transactions and previous rental payments amounting to RMB971,510.39 under the 2023 leasing agreements, with a right-of-use asset valued at RMB14,522,000. The company also disclosed the ownership details of BioAI and Yizhao (Beijing) Pharmaceutical Technology, indicating a mix of employee share options and independent third-party ownership.
For further insights into HK:6127 stock, check out TipRanks’ Stock Analysis page.